Preclinical Imaging Market 2024-2033 : Industry Analysis, Size, Share, Growth And Forecast | Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc

"The new report published by The Business Research Company, titled Preclinical Imaging Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth
The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person's quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging market.

Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility
Product innovations are a key trend gaining popularity in the preclinical imaging market. Major companies operating in the preclinical imaging market are developing innovative products to sustain their position in the market. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company that manufactures imaging systems, launched Vevo F2 for preclinical imaging. This innovative product is the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 features HD image processing technology and a completely new signal pathway, enabling better image clarity and better frame rates. The system is also customizable to fit the specific precision demands of imaging. Additionally, it includes features such as HD image processing technology, a completely new signal pathway, customizable system architecture, a wide range of anatomical targets, and high-resolution imaging. It is suitable for a variety of research applications.

The preclinical imaging market covered in this report is segmented -

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12393&type=discount

Major companies operating in the preclinical imaging market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Contents of the report:
1. Executive Summary
2. Preclinical Imaging Market Report Structure
3. Preclinical Imaging Market Trends And Strategies
4. Preclinical Imaging Market - Macro Economic Scenario
5. Preclinical Imaging Market Size And Growth
…..
27. Preclinical Imaging Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.